You are here: Industry Insights > Bayer

News List

Bayer transforms pharma business through breakthrough innovation in healthcare worldpharmanews
January 18, 2021
At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are currently still ...
Bayer announces FDA accepts NDA and grants priority review for Finerenone for patients with CKD and T2D pharmaceutical-business-review
January 18, 2021
Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted Priority Review for finerenone, an investigational drug for patients with chronic kidney disease (CKD) and type 2 diabetes (T2D).
Bayer examining if it can help CureVac with COVID-19 vaccine production: CEO expresspharma
January 18, 2021
CureVac's COVID-19 vaccine candidate is in late-stage clinical trials and has not yet been approved.
CureVac and Bayer Join Forces contractpharma
January 08, 2021
Bayer has signed a collaboration and services agreement with CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA).
Bayer, Arogya Finance join hands for Eylea Easy Pay Program in India expresspharma
December 22, 2020
Eylea or Aflibercept solution is indicated for the treatment of diabetic macular oedema (DME) and wet age-related macular degeneration (Wet AMD).
Bayer, Atara Biotherapeutics to partner for mesothelin-targeted CAR T-cell therapies expresspharma
December 08, 2020
The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version, ATA2271, for high mesothelin-expressing tumours such as malignant pleural mesothelioma and non-small-cell lung cancer.
Bayer establishes new cell and gene therapy platform pharmatimes
December 04, 2020
Bayer has launched a Cell and Gene Therapy (C>) Platform, aiming to accelerate its presence in this area.
Bayer inks deal with Blackford Analysis to develop radiology AI platform pharmatimes
December 03, 2020
German pharma company Bayer has signed an agreement with Scottish artificial intelligence (AI) specialist Blackford Analysis to develop an AI platform for medical imaging.
Bayer’s Nubeqa wins NICE prostate cancer backing pharmatimes
October 29, 2020
Bayer’s Nubeqa has scored backing from the UK’s National Institute for Health and Care Excellence (NICE) for treating non-metastatic castration-resistant prostate cancer (nmCRPC).
Bayer acquires gene therapy specialist AskBio for $4bn pharmaceutical-technology
October 28, 2020
Bayer has announced the acquisition of US-headquartered cell and gene therapy specialist Asklepios BioPharmaceutical (AskBio) in a deal worth $4bn.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page